Contact this trialFirst, we need to learn more about you.
Radio-protector
BMX-001 for Anal Cancer
Recruiting1 awardPhase 1 & 2
Omaha, Nebraska
This trial is testing a new combination of drugs for anal cancer. The first part is to see what dose is safe, and the second part is to see if it has fewer side effects than the standard treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service